Wanyi Hu
- Co-authors
- Guangrong ZhengDaohong ZhouYaxia YuanXingui LiuXuan ZhangPeiyi ZhangNathan J. SchauerXiaoxi Liu
- Topics
- Protein Degradation and Inhibitors (13 papers)Peptidase Inhibition and Analysis (9 papers)Ubiquitin and proteasome pathways (7 papers)
- Cited by
- OncologyHematologyMolecular Biology
- Partner nations
- United StatesChinaPoland
In The Last Decade
Wanyi Hu
18 papers receiving 437 citations
Peers
Comparison fields: 5 of 49
- Molecular Biology 387
- Oncology 180
- Hematology 72
- Epidemiology 45
- Cell Biology 27
Countries citing papers authored by Wanyi Hu
This map shows the geographic impact of Wanyi Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanyi Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanyi Hu more than expected).
Fields of papers citing papers by Wanyi Hu
This network shows the impact of papers produced by Wanyi Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanyi Hu. The network helps show where Wanyi Hu may publish in the future.
Co-authorship network of co-authors of Wanyi Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Wanyi Hu. A scholar is included among the top collaborators of Wanyi Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanyi Hu. Wanyi Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 23 | |
| 7 | 6 | |
| 8 | 3 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 48 | |
| 12 | 46 | |
| 13 | 2 | |
| 14 | 4 | |
| 15 | 1 | |
| 16 | 42 | |
| 17 | 26 | |
| 18 | 84 | |
| 19 | 137 |
About Wanyi Hu
Wanyi Hu is a scholar working on Hematology, Oncology and Molecular Biology, having authored 19 papers that have together received 439 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (13 papers), Peptidase Inhibition and Analysis (9 papers) and Ubiquitin and proteasome pathways (7 papers). The work is most often cited by research in Oncology (180 citations), Hematology (72 citations) and Molecular Biology (387 citations). Wanyi Hu has collaborated with scholars based in United States, China and Poland. Frequent co-authors include Guangrong Zheng, Daohong Zhou, Yaxia Yuan, Xingui Liu, Xuan Zhang, Peiyi Zhang, Nathan J. Schauer, Xiaoxi Liu, Sara J. Buhrlage and Sajid Khan. Their work appears in journals such as Nature Communications, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.